287 Xiangke Road
Pudong New District
Shanghai 201210
China
86 40 0828 5227
https://www.hspharm.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 9,123
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Huijuan Zhong | Chairlady, CEO & President | 1.43M | N/A | 1961 |
Mr. Aifeng Lyu | Executive Director | 325.45k | N/A | 1977 |
Ms. Yuan Sun | Executive Director | 883.73k | N/A | 1987 |
Mr. Min Hu | VP & CFO | N/A | N/A | 1977 |
Mr. Gongzheng Wu | Senior Vice President | N/A | N/A | 1971 |
Ms. Chunhua Zhong | Senior Vice President | N/A | N/A | 1975 |
Mr. Chuanhe Xu | Senior Vice President | N/A | N/A | 1964 |
Mr. Rudi Bao | Senior Vice President | N/A | N/A | 1964 |
Mr. Weiyong Sun | Chief Commercial Officer | N/A | N/A | 1971 |
Mr. Qiong Wu | Chief Medical Officer | N/A | N/A | 1969 |
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-tumor, anti-infection, central nervous system diseases, oncology, metabolic and autoimmune diseases, etc. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Hengmu, Mailingda, Hengsen, XINYUE, Saint Luolai, Fulaimei, Pulaitan, Tanneng, Ameining, Oulanning, Ruibote, Fulaidi, Fulairui, and Puruian tablets. The company serves pharmaceutical product distributors. It has licence agreements with GSK plc to develop, manufacture, and commercialise HS20089 and HS-20093; GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089; and Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product, as well as collaboration agreement with Antengene Corporation Limited to commercialize selinexor and any product containing or comprising Selinexor. In addition, it engages in trading business. The company was founded in 1995 and is headquartered in Shanghai, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Hansoh Pharmaceutical Group Company Limited’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 3; Board: 1; Shareholder Rights: 8; Compensation: 10.